The Age ·general ·2 hours ago

New research finds better antibiotics for treating deadly golden staph infection

New research reveals that flucloxacillin, traditionally used to treat golden staph, has a lower survival rate and higher risk of side effects. In a world-first trial, alternative antibiotics cefazolin and benzylpenicillin showed better outcomes, prompting a shift in treatment as golden staph causes over 1,000 Australian deaths annually. Caitlin Alsop, a survivor, emphasized timely and effective treatment is critical.

Summary by Glance · The Age

Newer
Next